4.2 Article

IgG4-related disease: nomenclature, clinical features, and treatment

Journal

SEMINARS IN DIAGNOSTIC PATHOLOGY
Volume 29, Issue 4, Pages 177-190

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.semdp.2012.08.002

Keywords

IgG4-related disease; Autoimmune pancreatitis; Chronic sclerosing sialadenitis; Retroperitoneal fibrosis; Rituximab

Ask authors/readers for more resources

Concepts about IgG4-related disease (IgG4-RD) are now emerging swiftly. The condition has been identified in virtually every organ system, and its features are often excellent mimickers of malignancies, infections, and other immune-mediated disorders. Recommendations for nomenclature were proposed by the Organizing Committee of the 2011 International IgG4-related disease Symposium, and guidelines for the pathologic diagnosis of this condition have been published by an international group of experts. Experience with treatment regimens is growing. Glucocorticoids and B-cell depletion strategies both appear to be effective and are the subject of ongoing studies. This article reviews the current thought and understanding of this disease with regard to nomenclature, organ system involvement, and approaches to therapy. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available